# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Isaac Newton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN011-SYN-TD
- Date: 1693-09-28
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rupert Okonkwo-Fairbanks, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for primary care visit for a year of poor sleep and appetite, two weeks of near-sleeplessness, and suspicious thoughts about friends, in a researcher who heats mercury and other metals. **S**

## Objective

PHQ-9: 20; GAD-7: 11; MoCA: 27; Hemoglobin: 14.6 g/dL; MCV: 91 fL; White blood cells: 6.1 10*3/uL; Platelets: 242 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.3 mmol/L; BUN: 15 mg/dL; Creatinine: 0.92 mg/dL; eGFR: 101 mL/min/1.73 m²; Glucose: 88 mg/dL; Calcium: 9.5 mg/dL; Albumin: 4.2 g/dL; ALT: 24 U/L; TSH: 1.9 mIU/L; Vitamin B12: 455 pg/mL; Urine albumin-to-creatinine ratio: 9 mg/g{creat}; Blood mercury: 9.4 ug/L (high); Blood lead: 2.4 ug/dL; 24-hour urine mercury: 46 ug/L (high); Urine mercury per gram creatinine: 41 ug/g{creat} (high). All results are synthetic.

BP 124/78 mmHg; pulse 84 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 64 kg; BMI 22.1 kg/m². All vital signs are synthetic.

## Assessment

Active problems: A year of poor sleep and poor appetite with 4 kg weight loss, two weeks of near-total sleeplessness, low spirits, and suspicious thoughts that colleagues and friends were plotting against him, now partly doubted; under evaluation for depression, a toxic cause, and other medical causes; Occupational exposure to elemental and inorganic mercury, with lesser exposure to lead, antimony, and arsenic compounds, from heating metals in an unventilated private laboratory. Strengths and supports remain part of the care plan. **S**

## Medication changes

- No medication changes. **S**

## Plan

- Workup for medical and toxic causes: blood count, metabolic panel, TSH, vitamin B12, MoCA, urine albumin-to-creatinine ratio and dipstick protein, blood mercury, 24-hour urine mercury with creatinine, and blood lead; examination for tremor, gingivitis, stomatitis, and neuropathy; no provoked (chelator-challenge) urine test and no broad metal screen. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013) **S**
- Removal from exposure now: stop all heating of metals, close the laboratory, and do not sleep in the adjoining rooms until they are checked; the university environmental health and safety office to measure mercury vapor, decontaminate, and remove the mercury and arsenic compounds. Guideline: Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013) **S**
- Suicide and violence risk assessment with a safety plan: warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; toxic chemicals out of reach; safety reviewed at every visit. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Occupational and environmental medicine (medical toxicology) consultation on the meaning of the mercury results, chelation, the workplace hazard assessment, and a safe return to laboratory work. Guideline: Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013) **S**
- Sleep: cognitive behavioral therapy for insomnia (a fixed rising time, a sleep window, out of bed after 20 minutes awake, no dozing in the evening chair, no night work); no hypnotics or sedating antihistamines. Guideline: Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016) **S**
- Nutrition: three regular meals a day, weight at every visit. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022) **S**
